1. Introduction {#sec1}
===============

Since the first global look at the content of the human genetic code, published more than a decade ago \[[@B1]\], it became clear that the implementation of genomic medicine has the potential of bringing clinically important advances, to rival those of any other major discovery in the history of medicine \[[@B2]\]. In this context, doctors have been envisaged as the key players in properly incorporating emerging DNA technologies in the health care system \[[@B3], [@B4]\], leading to calls for enhanced genomic education for healthcare professionals. Nevertheless, several studies conducted in USA, Europe, and Canada showed unsatisfactory level of clinicians\' ability to use genetic tests in clinical care \[[@B3]--[@B5]\].

Recent research showed that providing genetic educational outreach to doctors has a positive impact in improving their competency and confidence in the use of genetic testing to guide prevention or treatment decisions \[[@B6]--[@B8]\]. Although the importance of genomic education for health care professionals has been recognized even before completion of the Human Genome Project \[[@B9]\], many physicians do not feel to have a proper training and knowledge \[[@B3], [@B4]\].

Genetic tests for breast and colorectal cancer, if used appropriately, have been demonstrated to be efficacious and cost-effective \[[@B10]\]. However, Marzuillo et al. reported a significant lack of knowledge on*BRCA1/2* and*APC* tests among Italian medical doctors \[[@B5]\], irrespective of their specialty. Along similar lines, we conducted survey on Italian doctors attending postgraduate medical schools in order to examine the level of education they had received on genetic tests for breast and colorectal cancer during their recent medical training.

More specifically, our objective was to assess knowledge, attitudes, and educational needs of Italian residents related to the use of genetic tests for breast and colorectal cancer, particularly the*BRCA1/2* and*APC* tests, irrespective of the field of specialization.

2. Methods {#sec2}
==========

A self-administered anonymous questionnaire was distributed in 2011 to all the residents enrolled at the Gemelli Teaching Hospital of the Università Cattolica del Sacro Cuore in Rome, Italy. The total number of eligible participants was 754, and the number of surveyed postgraduate schools was 43.

A similar questionnaire was previously used and validated in a study conducted on a sample of Italian medical specialists \[[@B5]\]. It comprises questions designed to assess (i) demographic and professional characteristics; (ii) knowledge and attitudes towards genetic tests for hereditary breast and colorectal cancer; (iii) self-assessed level of knowledge and training needs.

Knowledge of genetic tests for breast and colorectal cancer was investigated with three questions, each using a three-point options Likert scale ("agree," "uncertain," and "disagree"). Additional four multiple-choice questions were designed to evaluate the residents\' knowledge of prevalence of hereditary breast cancer and inherited forms of colorectal cancer and of penetrance of*BRCA1/BRCA2*and*APC* mutations (two each).

Attitudes towards genetic tests for breast and colorectal cancers were assessed with seven different questions, also using a Likert scale evaluation.

The final set of questions required the residents to assess their own perceived level of knowledge according to a four-answer format ("inadequate," "sufficient," "good," and "excellent"), and training needs ("yes/no" answer).

2.1. Statistical Analysis {#sec2.1}
-------------------------

A descriptive analysis was conducted to report demographic, social, and professional characteristics of responding residents. For the questions on knowledge and attitudes of residents towards genetic testing for breast and colorectal cancer, we calculated the proportions of correct answers (plus 95% confidence intervals (CI)). We considered residents who gave 80% correct answers for each form of hereditary cancer as knowledgeable. A general positive attitude towards predicative genetic testing was defined as the presence of a positive attitude in at least 70% of the questions assessing the attitude. Variables associated (*P* value of \<0.20) with a positive outcome (satisfactory knowledge/attitude) from the univariate analysis were included in the multivariate conditional logistic regression model. A backward elimination procedure was used for the multivariate analysis. Data were analyzed using Stata software (StataCorp. 2009. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP).

3. Results {#sec3}
==========

Of the initial number of 754 eligible for inclusion, 364 residents responded (overall response rate 48.3%).

The demographic and professional characteristics of responding residents are reported in [Table 1](#tab1){ref-type="table"}. Among respondents, 61.2% (222/364) were female; the age mode was of 28-29 years (151/364, 41.6%) and 63.1% (224/364) have had their specialization associated with clinical activity.

Majority of included residents (67.3%, 245/364) answered correctly at least 80% of questions on genetic tests for breast cancer, prevalence of hereditary forms, and penetrance of*BRCA* mutations. Residents knowledgeable on genetic tests for colorectal cancer, prevalence of hereditary forms, and penetrance of*APC* mutations were 21.2% (77/364). [Table 2](#tab2){ref-type="table"} reports the correct answer rates in relation to each particular question. The knowledge on test for breast cancer was higher among residents who reported having attended a specific cancer course on genetic testing during their graduate training (OR: 1.72; 95% CI: 1.05--2.82) ([Table 3](#tab3){ref-type="table"}). Male gender was inversely associated with knowledge on tests for breast cancer (OR: 0.55; 95% CI: 0.35--0.87) ([Table 3](#tab3){ref-type="table"}). Residents who attended a specific cancer course on genetic testing during the graduate training (OR: 2.08; 95% CI: 1.07--4.03) as those who took postgraduate training courses in epidemiology and evidence-based medicine (EBM) (OR: 1.95; 95% CI: 1.03--3.69) showed higher knowledge on test for colorectal cancer ([Table 3](#tab3){ref-type="table"}).

Residents\' attitudes towards genetic testing for breast and colorectal cancer are reported in [Table 4](#tab4){ref-type="table"}. A total of 45.6% showed positive attitude in at least 70% of questions. Less than half appeared to comply with principles of efficacy (attitude number 2, 48.3%) and cost-effectiveness (attitude number 3, 46.3%) in this field ([Table 4](#tab4){ref-type="table"}). When we analyzed predictors of positive attitude towards genetic testing; only personal family history of breast and/or colorectal cancer (OR: 1.74; 95% CI: 1.11--2.71) appeared to be significantly associated.

[Table 5](#tab5){ref-type="table"} reports the self-estimated level of knowledge on genetic tests for breast and colorectal cancer and training needs of participants. More than half of our sample (178/364, 50.6%) described their knowledge as poor and 84.6% (296/364) declared that they did not feel qualified to prescribe genetic tests ([Table 5](#tab5){ref-type="table"}). Conversely, 87.8% (309/364) of them declared that is was important for them to increase their knowledge in this field ([Table 5](#tab5){ref-type="table"}). The majority of residents felt that more training time should be allotted to genetic testing during medical studies (289/364, 82.3%) or specialization school (263/364, 74.7%) or through specific postgraduate courses (289/229, 65.4%).

4. Discussion {#sec4}
=============

Our study reports unsatisfactory level of residents\' knowledge on genetic tests for colorectal cancer and on prevalence of hereditary forms and penetrance of*APC* mutations. We identified female gender and attendance to cancer genetic testing courses during graduate training to be predictors of a better knowledge of genetic tests for breast cancer. An attendance to cancer genetic testing courses during the graduate training and postgraduate training courses in epidemiology end EBM were associated with better knowledge on genetic tests on colorectal cancer. Although the vast majority of participants recognized the important role of genetic tests in prevention, as well as the need for evidence-based guidelines, complex prevention strategies, and genetic counseling, the principles of efficacy and cost-effectiveness appear to be not so widely accepted. The self-assessment revealed that participants are not satisfied with their own knowledge of genetic test and that they do not feel qualified to prescribe them. However, the need for training in this field during graduate and postgraduate studies was clearly recognized.

Some surveys already reported lack of knowledge among medical doctors on genetic tests for cancer \[[@B5], [@B11]--[@B20]\]. Nevertheless, most of these were conducted among specialists, while only one referred to residents \[[@B18]\]. Younger age \[[@B20]\] and recent graduation from medical school \[[@B21]\], as well as being in medical practice less than 10 years \[[@B11]\], have been previously reported as predictors of better knowledge on genetic tests and increased confidence in using them in everyday practice. Marzuillo et al. \[[@B5]\] previously reported insufficient knowledge on genetic test on breast and colorectal cancer among Italian specialists. Although our study showed relatively more satisfactory results in relation to tests for breast cancer, knowledge on genetic tests on colorectal cancer among residents in our study was also fairly low, indicating the need for further improvement in specialists formatting process. Finally, our results clearly pointed the need for additional education in field of genomics as exposure to genetic test during graduate training as well as postgraduate training courses in epidemiology and EBM were associated with higher knowledge on genetic test for breast and colorectal cancer.

Attitude of medical doctors is crucial for the dissemination and implementation of new medical technologies. Although residents in our study have shown high rates of some individual positive attitudes towards genetic testing, only a minority showed positive attitude in all issues. Furthermore, the majority of residents do not recognize the importance of the principles of efficacy and cost-effectiveness in genetic testing. Similar results were obtained from the survey on Italian specialists, who also did not show cost-conscious behavior regarding genetic tests \[[@B5]\]. This could lead to introducing of genetic test in clinical practice for commercial purposes only. Having that in mind, specific educational programs and trainings are needed in order to promote more cost-conscious behavior of physicians.

We found that family history of breast and/or colorectal cancer was a significant predictor of positive attitude towards genetic testing. This is to be expected, as personal experiences represent a major influence in determining individual attitudes, and those with positive family cancer history were personally motivated to find out more on genetic tests.

Residents in our study have deemed their knowledge of genetic tests for breast and colorectal cancer insufficient. Insufficient level of knowledge on genetic test has been previously self-reported among medical doctors several times \[[@B5], [@B15]\]. Our residents also reported a high level of interest in additional training in this field. As earlier studies also reported readiness of physicians to attend additional courses on genetic testing \[[@B5], [@B11], [@B15], [@B18]\], an organized approach to genomics education is needed in order to make the best use of available genetic testing resources.

Our study has some limitations. Firstly, we have conducted our research among residents working in the same hospital, so the results may not be reflecting the knowledge and attitudes of the Italian residents\' population. Secondly, our nonresponse rate was relatively high; thus we do not have data on age and gender structure of nonresponders. Although it is not likely that age could differ between responders and nonresponders, as most of the residents belong to the same age group, the difference in gender structure may be an issue as we recognized gender to be factor for knowledge in some specific fields. Nevertheless, our study is, to our knowledge, first in Europe reflecting the knowledge and attitudes of residents on genetic tests and can be valuable in assessing knowledge, attitudes, and educational needs of young doctors in training on a wider scale.

In conclusion, knowledge of Italian residents on genetic tests for colorectal cancer appears to be insufficient. There is a need for additional training in field of genetic tests during graduate and postgraduate studies as well as during specializations. The principles of efficacy and cost-effectiveness in genetic testing are not fully accepted among residents. Specific educational programs are needed in order to promote more cost-conscious behavior.
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###### 

The demographic and professional characteristics of responding residents (*n* = 364).

  Variables                                                                    n     \%
  ---------------------------------------------------------------------------- ----- -------
  Gender                                                                              
   Male                                                                        141   38.8%
   Female                                                                      222   61.2%
  Age (years)                                                                         
   \<28                                                                        78    21.5%
   28-29                                                                       151   41.6%
   30-31                                                                       84    23.1%
   ≥32                                                                         50    13.8%
  Professional area^i^                                                                
   Medicine                                                                    147   40.4%
   Surgery                                                                     47    12.9%
   Others                                                                      170   46.7%
  Clinical activity                                                                   
   No                                                                          131   36.9%
   Yes                                                                         224   63.1%
  Exposure to cancer genetic testing during graduate training                         
   No                                                                          95    26.7%
   Yes                                                                         261   73.3%
  Postgraduate training courses in epidemiology and EBM                               
   No                                                                          292   83.0%
   Yes                                                                         60    17.1%
  English language knowledge                                                          
   Very low                                                                    9     2.5%
   Low                                                                         38    10.6%
   Intermediate                                                                130   36.3%
   Good                                                                        153   42.7%
   Excellent                                                                   28    7.8%
  Hours per week dedicated to continuing medical education                            
   \<1                                                                         48    13.5%
   1--5                                                                        212   59.4%
   6--10                                                                       73    20.5%
   \>10                                                                        24    6.7%
  Patient request of cancer genetic tests in the previous year∗                       
   No                                                                          162   74.0%
   Yes                                                                         57    26.0%
  Personal or family history of breast cancer                                         
   No                                                                          292   81.8%
   Yes                                                                         65    18.2%
  Personal or family history of colorectal cancer                                     
   No                                                                          285   80.1%
   Yes                                                                         71    19.9%
  Promotional material about breast cancer received in the previous year              
   No                                                                          311   86.9%
   Yes                                                                         47    13.1%
  Promotional material about colorectal cancer received in the previous year          
   No                                                                          325   91.0%
   Yes                                                                         32    9.0%

EBM: evidence based medicine.

^i^List of specializations according to each area is available in Supplementary Material S1 available online at <http://dx.doi.org/10.1155/2014/418416>.

∗The number of responders was 219 as only physicians with clinical activity were included.

###### 

Knowledge of residents (*n* = 364) on genetic tests for breast and colorectal cancer, prevalence of hereditary forms, and penetrance of *BRCA1/2*and *APC* mutations.

                                                                                                                                                                       Number of responders to the question   \% of correct answers   CI 95%
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------- ----------------------- ------------
  *BRCA1/2*                                                                                                                                                                                                                            
   Genetic tests for BRCA1/BRCA2 mutations are able to identify patients at high risk to develop  breast cancer (**agree**, uncertain, disagree)                       357                                    93.3                    90.2--95.6
   The percentage of breast cancer cases associated with mutations in BRCA1/BRCA2 is **1**--**10%**,  15--35%, \>35%                                                   354                                    42.9                    37.7--48.3
   The absolute risk of developing breast cancer in presence of BRCA1/BRCA2 mutations is  \<10%, **40**--**80%**, 100%                                                 356                                    80.3                    75.8--84.3
   Women with breast cancer and strong family history should perform BRCA1/BRCA2 testing  (**agree**, uncertain, disagree)                                             356                                    78.7                    74.0--82.8
   Scientific evidence recommend for BRCA1/BRCA2 positive women clinical and instrumental  surveillance starting from the age of 25 (**agree**, uncertain, disagree)   358                                    84.4                    80.2--88.0
  *APC*                                                                                                                                                                                                                                
   Genetic tests for APC mutations are able to identify patients who will develop colorectal  carcinoma (**agree**, uncertain, disagree)                               355                                    77.7                    73.1--82.0
   The percentage of colon cancer cases associated with APC mutations is **\<5%**, 10--25%, \>40%                                                                      352                                    31.8                    27.0--37.0
   The absolute risk of developing colorectal cancer in presence of APC mutations is \<10%,  40--80%, **100%**                                                         351                                    27.9                    23.3--32.9
   APC testing is recommended for 10--12 years old children with a first degree relative with  known APC mutation (**agree**, uncertain, disagree)                     357                                    57.4                    52.1--62.6
   Scientific evidence recommend for APC positive individuals periodic colonoscopy starting  from the age of 10--15 (**agree**, uncertain, disagree)                   356                                    55.9                    50.6--61.1

Correct answers are in bold.

###### 

Sociodemographic and professional characteristics associated with knowledge on genetic testing for breast cancer (*BRCA1/BRCA2* mutations) and colorectal cancer (*APC* mutations).

                                                                                    Breast cancer   Colorectal cancer                                                  
  --------------------------------------------------------------------------------- --------------- ------------------- ------ ------------ ------ ------------ ------ ------------
  Gender                                                                                                                                                                
   Female                                                                           1.00                                1.00                1.00                1.00    
   Male                                                                             0.53            0.34--0.83          0.55   0.35--0.87   1.24   0.74--2.06   1.36   0.80--2.31
  Age                                                                                                                                                                   
   \<28                                                                             1.00                                1.00                1.00                1.00    
   28-29                                                                            0.72            0.39--1.32          0.66   0.35--1.24   0.78   0.42--1.43   0.74   0.39--1.41
   30-31                                                                            0.70            0.36--1.37          0.62   0.31--1.26   0.32   0.14--0.73   0.25   0.10--0.61
   ≥32                                                                              0.71            0.33--1.54          0.68   0.30--1.56   0.39   0.15--0.99   0.33   0.12--0.92
  Personal or family history of breast or colon cancer                                                                                                                  
   No                                                                               1.00                                1.00                1.00                1.00    
   Yes                                                                              1.40            0.77--2.57          1.21   0.65--2.25   0.98   0.52--1.86   0.91   0.47--1.77
  Professional area^\~^                                                                                                                                                 
   Medicine                                                                         1.00                                1.00                1.00                1.00    
   Surgery                                                                          0.60            0.31--1.17          0.80   0.39--1.64   1.10   0.50--2.40   1.24   0.55--2.80
   Others                                                                           1.16            0.72--1.87          1.20   0.74--1.96   0.90   0.52--1.55   0.88   0.50--1.55
  Clinical activity                                                                                                                                                     
   No                                                                               1.00                                1.00                1.00                1.00    
   Yes                                                                              0.94            0.59--1.50          0.97   0.60--1.57   0.93   0.55--1.58   1.02   0.59--1.76
  Exposure to cancer genetic testing during graduate training                                                                                                           
   No                                                                               1.00                                1.00                1.00                1.00    
   Yes                                                                              1.73            1.06--2.82          1.72   1.05--2.82   2.01   1.05--3.84   2.08   1.07--4.03
  Postgraduate training courses in epidemiology and EBM                                                                                                                 
   No                                                                               1.00                                1.00                1.00                1.00    
   Yes                                                                              0.90            0.50--1.61          0.88   048--1.60    1.85   1.01--3.45   1.95   1.03--3.69
  Patient request of cancer genetic tests in the previous year^i^                                                                                                       
   No                                                                               1.00                                1.00                1.00                1.00    
   Yes                                                                              2.15            1.05--4.38          1.84   0.89--3.83   0.90   0.42--1.92   0.84   0.38--1.84
  Hours per week dedicated to continuing medical education                                                                                                              
   \<1                                                                              1.00                                1.00                1.00                1.00    
   1--5                                                                             1.45            0.76--2.75          1.39   0.71--2.73   1.31   0.57--3.00   0.98   0.41--2.30
   6--10                                                                            2.03            0.93--4.41          2.11   0.93--4.77   1.64   0.65--4.14   1.25   0.48--3.29
   \>10                                                                             1.73            0.61--4.96          1.84   0.62--5.43   1.32   0.38--4.56   0.74   0.19--2.91
  Promotional material about breast or colon cancer received in the previous year                                                                                       
   No                                                                               1.00                                1.00                1.00                1.00    
   Yes                                                                              1.29            0.65--2.56          1.12   0.56--2.25   0.67   0.25--1.82   0.41   0.14--1.25

OR: odds ratio; CI: confidence interval; EBM: evidence based medicine.

∗OR adjusted by professional area, exposure to cancer genetic testing during graduate training.

^*γ*^OR adjusted by gender, postgraduate training courses about epidemiology and EBM.

^\~^List of specializations according to each area is available in Supplementary file S1.

^i^Included physicians with clinical activity.

###### 

Attitudes of residents (*n* = 364) towards genetic testing for breast and colorectal cancer.

                                                                                                                                                                                                                                                                   Number of responders to the question   \% of correct answers   CI 95%
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------- ----------------------- ------------
  \(1\) Genetic tests for breast cancer and colorectal cancer increase the chances of prevention opportunities (**agree**, uncertain, disagree)                                                                                                                    355                                    85.1                    80.9--88.6
  \(2\) Genetic tests that able to identify an increased risk of developing breast or colorectal cancer should be performed even if there are no preventive and/or curative interventions of proven efficacy (agree, uncertain, **disagree**)                      352                                    48.3                    43.0--53.6
  \(3\) Genetic tests for breast cancer or colorectal cancer should be performed only if economical evaluations show cost effectiveness ratios favorable compared to alternative health interventions (**agree**, uncertain, disagree)                             354                                    46.3                    41.0--51.7
  \(4\) Authoritative and evidence-based guidelines are needed for the appropriate use of genetic tests for breast cancer and colorectal cancer (**agree**, uncertain, disagree)                                                                                   355                                    92.4                    89.1--94.9
  \(5\) Genetic tests for breast and colorectal cancer should be performed without genetic counseling informing patients of the benefits and risks of the tests (agree, uncertain, **disagree**)                                                                   355                                    76.9                    72.2--81.2
  \(6\) Genetic tests for breast and colorectal cancer can contribute efficaciously to health promotion and cancer prevention only if included in wider strategies taking into account the other available health interventions (**agree**, uncertain, disagree)   354                                    83.1                    78.7--86.8
  \(7\) The implementation of genetic tests for breast and colorectal cancer, being a medical matter, should not take into account ethical, legal and social implications (agree, uncertain, **disagree**)                                                         356                                    75.3                    70.4--80.0

Correct answers bolded.

###### 

Self-estimated level of residents\' knowledge and training needs on genetic tests for breast and colorectal cancer (*n* = 364).

  ---------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                        *n*       \%
  ------------------------------------------------------------------------------------------------------------------------------ ------ --------- ---------
  How would you rate your level of knowledge on the appropriate use of genetics tests for cancer in clinical practice?           Poor   178       50.6

  Fair                                                                                                                           143    40.6      

  Good                                                                                                                           29     8.2       

  Excellent                                                                                                                      2      0.6       

                                                                                                                                                  

                                                                                                                                        Yes       No

                                                                                                                                                  

  How important do you think it is to increase your knowledge about the use of genetics tests for cancer in clinical practice?          309\      43\
                                                                                                                                        (87.8%)   (12.2%)

  Do you find yourself qualified enough to prescribe genetic tests for cancer?                                                          54\       296\
                                                                                                                                        (15.4%)   (84.6%)

  Should more time be dedicated to learning on genetic test during the medical studies?                                                 289\      62\
                                                                                                                                        (82.3%)   (17.7%)

  Should more time be dedicated to learning on genetic test during the medical specialization?                                          263\      89\
                                                                                                                                        (74.7%)   (25.3%)

  Is there a need for specific postgraduate course on use of genetic testing for cancer?                                                229\      121\
                                                                                                                                        (65.4%)   (34.6%)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------
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